HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles
Breast Cancer Research and Treatment · 2025
DOI: 10.1007/s10549-024-07497-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Ekaterina S Kuligina und 10 weiteren Autor:innen. Beteiligte Einrichtung: N.N. Petrov Institute of Oncology, St. Petersburg, Russia. kate.kuligina@gmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Penetrance, Polymorphism, Genetic, HLA Antigens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
PURPOSE: Female carriers of germline BRCA1 mutations almost invariably develop breast cancer (BC); however, the age at onset is a subject of variation. We hypothesized that the age-related penetrance of BRCA1 mutations may depend on inherited variability in the host immune system. METHODS: Next-generation sequencing was utilized for genotyping of HLA class I/II genes (HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQB1, and HLA-DRB1/3/4/5) in patients with BRCA1-associated BC with early ( / = 58 years, n = 108) age at onset. RESULTS: HLA-DQB1*06:03P prevalence was higher in the late-onset group due to the excess of allele carriers [25/108 (23.1%) vs. 22/215 (10.2%); OR 2.96, p < 0.001]. For all HLA-I loci, there was a trend toward an increase in the number of homozygotes in the early-onset group. This trend reached statistical significance for the HLA-A [14.4% vs. 6.5%, p = 0.037; OR 2.4, p = 0.042]. The frequencies of HLA-DPB1, HLA-DQB1, and HLA-DRB1/3/4/5 homozygous genotypes did not differ between young-onset and late-onset patients. The maximum degree of homozygosity detected in this study was 6 out of 7 HLA class I/II loci; all six carriers of these genotypes were diagnosed with BC at the age < / = 38 years [OR 6.97, p = 0.187]. CONCLUSION: HLA polymorphism may play a role in modifying the penetrance of BRCA1 pathogenic variants. Certain HLA alleles or HLA homozygosity may modify the risk of BC in BRCA1 carriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- N.N. Petrov Institute of Oncology, St. Petersburg, Russia. kate.kuligina@gmail.com.
- Laboratory of Molecular Oncology, N.N. Petrov Institute of Oncology, Pesochny-2, St. Petersburg, Russia, 197758. kate.kuligina@gmail.com.
- N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
- St. Petersburg Pediatric Medical University, St. Petersburg, Russia.
- DNA-Technology LLC, Moscow, Russia.
- International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Förderung
- Russian Science Foundation
Zitieren
APA
Kuligina, E. S., Romanko, A. A., Jankevic, T., Martianov, A. S., Ivantsov, A. O., Sokolova, T. N., Trofimov, D., Kashyap, A., Cybulski, C., Lubiński, J., & Imyanitov, E. N. (2025). HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07497-2
Vancouver
Kuligina ES, Romanko AA, Jankevic T, Martianov AS, Ivantsov AO, Sokolova TN, et al. HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-024-07497-2
BibTeX
@article{Kuligina2025,
author = {Kuligina, Ekaterina S and Romanko, Alexandr A and Jankevic, Tatjana and Martianov, Aleksandr S and Ivantsov, Alexandr O and Sokolova, Tatyana N and Trofimov, Dmitry and Kashyap, Aniruddh and Cybulski, Cezary and Lubiński, Jan and Imyanitov, Evgeny N},
title = {HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles},
journal = {Breast Cancer Research and Treatment},
year = {2025},
doi = {10.1007/s10549-024-07497-2}
}
EUVIMED